Trends and Patterns of Utilization in Post-treatment Surveillance Imaging Among Patients Treated for Hepatocellular Carcinoma |
| |
Authors: | Omar Hyder Rebecca M Dodson Matthew Weiss David P Cosgrove Joseph M Herman Jean-Francois H Geschwind Ihab R Kamel Timothy M Pawlik |
| |
Institution: | 1. Department of Surgery, Johns Hopkins University School of Medicine, Blalock 688 600N. Wolfe Street, Baltimore, MD, 21287, USA 2. Department of Medical Oncology, Johns Hopkins University School of Medicine, Blalock 688 600N. Wolfe Street, Baltimore, MD, 21287, USA 3. Department of Radiation Oncology, Johns Hopkins University School of Medicine, Blalock 688 600N. Wolfe Street, Baltimore, MD, USA 4. Department of Radiology and Radiological Sciences, Johns Hopkins University School of Medicine, Blalock 688 600N. Wolfe Street, Baltimore, MD, USA
|
| |
Abstract: | Background Little is known about the patterns of utilization of surveillance imaging after treatment of hepatocellular carcinoma (HCC). We sought to define population-based patterns of surveillance and investigate if intensity of surveillance impacted outcome following HCC treatment. Methods The Surveillance, Epidemiology, and End Results-Medicare database was used to identify patients with HCC diagnosed between 1998 and 2007 who underwent resection, ablation, or intra-arterial therapy (IAT). The association between imaging frequency and long-term survival was analyzed. Results Of the 1,467 patients, most underwent ablation only (41.5 %), while fewer underwent liver resection only (29.6 %) or IAT only (18.3 %). Most patients had at least one CT scan (92.7 %) during follow-up, while fewer had an MRI (34.1 %). A temporal trend was noted with more frequent surveillance imaging obtained in post-treatment year 1 (2.5 scans/year) vs. year 5 (0.9 scans/year; P?=?0.01); 34.5 % of alive patients had no imaging after 2 years. Frequency of surveillance imaging correlated with procedure type (total number of scans/5 years, resection, 4.7; ablation, 4.9; IAT, 3.7; P?<?0.001). Frequency of surveillance imaging was not associated with a survival benefit (three to four scans/year, 49.5 months vs. two scans/year, 71.7 months vs. one scan/year, 67.6 months; P?=?0.01) Conclusion Marked heterogeneity exists in how often surveillance imaging is obtained following treatment of HCC. Higher intensity imaging does not confer a survival benefit. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|